217 filings
Page 8 of 11
8-K
e43 ojnowi
11 Jan 11
87% Response Rate Achieved in a Broad Measure of Clinical Improvement
12:00am
8-K
fj2 qea37sn92uey05o6
28 Dec 10
Departure of Directors or Certain Officers
12:00am
8-K
9iepo b5q06lxf
27 Dec 10
Regulation FD Disclosure
12:00am
8-K
o67zu2j ebp0o7p
9 Dec 10
Other Events
12:00am
8-K
mu918t1zen5o6k
16 Nov 10
Results of Operations and Financial Condition
12:00am
8-K
t5nlirbshkmn199tge0
5 Oct 10
Other Events
12:00am
8-K
zte3zx0 k37m
22 Sep 10
Departure of Directors or Certain Officers
12:00am
8-K
lzy rpgw3qn
31 Aug 10
Other Events
12:00am
8-K
6wznh
16 Aug 10
Corcept Therapeutics Announces Second Quarter Results and Corporate and Development Update
12:00am
8-K
bwmba39 2gi
5 Aug 10
Departure of Directors or Certain Officers
12:00am
8-K
5z3dn
28 Jun 10
Submission of Matters to a Vote of Security Holders
12:00am
8-K
5o38k5
25 Jun 10
Corcept Therapeutics Nears Completion of Enrollment In Phase 3 Cushing’s
12:00am
8-K
wg179lf18e
25 Jun 10
Corcept Therapeutics Announces Pricing of $15 Million
12:00am
8-K
jhrwxi5iwxf8ptxyp wy
12 May 10
Results of Operations and Financial Condition
12:00am
8-K
d0ffevxh
5 May 10
Regulation FD Disclosure
12:00am
8-K
amylwt031lh8kck3
23 Apr 10
Corcept Therapeutics Announces Exercise of Existing Warrants
12:00am
8-K
0lp4pzevg2tvxa
25 Mar 10
Results of Operations and Financial Condition
12:00am
8-K
mh772by9pxc7x 56ko
8 Jan 10
Departure of Directors or Certain Officers
12:00am
8-K
uzux8
7 Jan 10
Four Anticipated Milestones for 2010
12:00am
8-K
j78ulb5c jfivjkj66
12 Nov 09
And Third Quarter 2009 Financial Results
12:00am